Impact of recurrent hypoglycemia on brain glucose transport kinetics in type 1 diabetes
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgag205 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Elizabeth R Seaquist und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Medicine, University of Minnesota, Minneapolis, MN 55455, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Hypoglycemia, Glucose, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, NINDS NIH HHS, NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
Impaired awareness of hypoglycemia (IAH) significantly impacts efforts to maintain optimal glycemia. Impaired awareness of hypoglycemia occurs when recurrent episodes of hypoglycemia (HG) occur within a short period of time, but the mechanisms are unknown. Upregulation of glucose transport may contribute to the development of IAH.
Objective
To determine if brain glucose transport is upregulated in response to recurrent HG in people with type 1 diabetes (T1D) and normal awareness of hypoglycemia.
Methods
Participants were recruited from a clinical registry. Inclusion criteria were diagnosis of T1D, 18-65 years, hemoglobin A1C < 8.5%, and diabetes duration of 2-25 years. Exclusion criteria included IAH on the Clarke and Gold questionnaires. Forty-five subjects enrolled and 30 completed the entire 3-day protocol. Participants underwent magnetic resonance spectroscopy scans at 3 tesla during which they were clamped at 150, 225, or 300 mg/dL before and after exposure to three 2-hour HG (target = 50 mg/dL) clamps over 2 days between December 2020 and June 2023. The primary metabolite of interest was glucose. Brain glucose transport kinetics were measured in the hypothalamus (HTL) and prefrontal cortex (PFC) during hyperglycemic clamps using reversible symmetric Michaelis–Menten model.
Results
Brain glucose transport kinetics measured during hyperglycemic clamps was not different before vs after exposure to recurrent HG clamps.
Conclusion
Short-term exposure to recurrent HG does not upregulate glucose transport kinetics in the setting of T1D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, School of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
- Center for Magnetic Resonance Research and Department of Radiology, School of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
- Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
- Department of Radiology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
- Division of Biostatistics & Health Data Science, School of Public Health, University of Minnesota, Minneapolis, MN 55455, USA.
ORCID-Profile: Elizabeth R Seaquist, Lynn Eberly
Förderung
- NIBIB NIH HHS
- NINDS NIH HHS
- NIH HHS
- NIH
- National Institutes of Health
Zitieren
APA
Seaquist, E. R., Park, Y. W., Kumar, A., Alvear, A., Zhang, L., Strong, B., Eberly, L., Henry, P. G., & Öz, G. (2026). Impact of recurrent hypoglycemia on brain glucose transport kinetics in type 1 diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag205
Vancouver
Seaquist ER, Park YW, Kumar A, Alvear A, Zhang L, Strong B, et al. Impact of recurrent hypoglycemia on brain glucose transport kinetics in type 1 diabetes. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag205
BibTeX
@article{Seaquist2026,
author = {Seaquist, Elizabeth R and Park, Young Woo and Kumar, Anjali and Alvear, Alison and Zhang, Lujun and Strong, Brent and Eberly, Lynn and Henry, Pierre-Gilles and Öz, Gülin},
title = {Impact of recurrent hypoglycemia on brain glucose transport kinetics in type 1 diabetes},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag205}
}
EUVIMED